J Scott Wolchko is President and CEO of FATE THERAPEUTICS INC. Currently has a direct ownership of 371,248 shares of FATE, which is worth approximately $742,496. The most recent transaction as insider was on Jan 09, 2024, when has been sold 14,391 shares (Common Stock) at a price of $4.37 per share, resulting in proceeds of $62,888. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K
0% 3M change
3.73% 12M change
Total Value Held $742,496

J Scott Wolchko Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2024
SELL
Open market or private sale
$62,888 $4.37 p/Share
14,391 Reduced 3.73%
371,248 Common Stock
Jan 10 2023
SELL
Open market or private sale
$240,552 $5.24 p/Share
45,907 Reduced 10.64%
385,639 Common Stock
Jul 22 2022
SELL
Open market or private sale
$202,433 $32.41 p/Share
6,246 Reduced 1.43%
431,546 Common Stock
Jul 22 2022
BUY
Exercise of conversion of derivative security
$16,864 $2.7 p/Share
6,246 Added 1.41%
437,792 Common Stock
Jul 21 2022
SELL
Open market or private sale
$984,300 $32.81 p/Share
30,000 Reduced 6.5%
431,546 Common Stock
Jul 21 2022
BUY
Exercise of conversion of derivative security
$81,000 $2.7 p/Share
30,000 Added 6.1%
461,546 Common Stock
Apr 22 2022
SELL
Open market or private sale
$348,500 $34.85 p/Share
10,000 Reduced 2.26%
431,546 Common Stock
Apr 22 2022
BUY
Exercise of conversion of derivative security
$27,000 $2.7 p/Share
10,000 Added 2.21%
441,546 Common Stock
Apr 21 2022
SELL
Open market or private sale
$1,086,900 $36.23 p/Share
30,000 Reduced 6.5%
431,546 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$81,000 $2.7 p/Share
30,000 Added 6.1%
461,546 Common Stock
Jan 21 2022
SELL
Open market or private sale
$380,200 $38.02 p/Share
10,000 Reduced 2.26%
431,546 Common Stock
Jan 21 2022
BUY
Exercise of conversion of derivative security
$27,000 $2.7 p/Share
10,000 Added 2.21%
441,546 Common Stock
Jan 20 2022
SELL
Open market or private sale
$1,206,300 $40.21 p/Share
30,000 Reduced 6.5%
431,546 Common Stock
Jan 20 2022
BUY
Exercise of conversion of derivative security
$81,900 $2.73 p/Share
30,000 Added 6.1%
461,546 Common Stock
Jan 11 2022
SELL
Open market or private sale
$710,675 $48.79 p/Share
14,566 Reduced 3.27%
431,546 Common Stock
Jan 10 2022
SELL
Open market or private sale
$1,608,065 $47.08 p/Share
34,156 Reduced 7.11%
446,112 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
-
86,475 Added 15.26%
480,268 Common Stock
Nov 18 2021
SELL
Open market or private sale
$1,085,400 $54.27 p/Share
20,000 Reduced 4.83%
393,793 Common Stock
Nov 18 2021
BUY
Exercise of conversion of derivative security
$54,000 $2.7 p/Share
20,000 Added 4.61%
413,793 Common Stock
Oct 22 2021
SELL
Open market or private sale
$1,766,400 $58.88 p/Share
30,000 Reduced 7.08%
393,793 Common Stock
Oct 22 2021
BUY
Exercise of conversion of derivative security
$102,600 $3.42 p/Share
30,000 Added 6.61%
423,793 Common Stock
Oct 21 2021
SELL
Open market or private sale
$1,806,900 $60.23 p/Share
30,000 Reduced 7.08%
393,793 Common Stock
Oct 21 2021
BUY
Exercise of conversion of derivative security
$81,900 $2.73 p/Share
30,000 Added 6.61%
423,793 Common Stock
Aug 19 2021
SELL
Open market or private sale
$1,760,200 $88.01 p/Share
20,000 Reduced 4.83%
393,793 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$96,800 $4.84 p/Share
20,000 Added 4.61%
413,793 Common Stock
JSW

J Scott Wolchko

President and CEO
San Diego, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE